U.S. markets closed

HCW Biologics Inc. (HCWB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.9200+0.2200 (+8.15%)
At close: 4:00PM EDT
2.9200 0.00 (0.00%)
After hours: 04:21PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close2.7000
Bid2.9200 x 900
Ask3.1400 x 1200
Day's Range2.7000 - 2.9400
52 Week Range2.3600 - 7.7750
Avg. Volume153,761
Market Cap104.314M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.6420
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HCWB

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • HCW Biologics Inc.
    Daily – Vickers Top Insider Picks for 10/27/2021The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Fair Value
    Economic Moat
    14 hours agoArgus Research
View more
  • GlobeNewswire

    HCW Biologics Announces Appointment of Two New Members to Board of Directors

    New Members Add Depth to Board with Experience in Strategic Transactions, Strategy and Commercial Planning, and GovernanceMIRAMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced the appointment of two new independent directors

  • Simply Wall St.

    Recent gains in HCW Biologics Inc. (NASDAQ:HCWB) help add back some value on insider purchases worth US$6.8m, still down US$4.0m

    Some of the losses seen by insiders who purchased US$6.8m worth of HCW Biologics Inc. ( NASDAQ:HCWB ) shares over the...

  • Benzinga

    4 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. HCW Biologics The Trade: HCW Biologics Inc. (NASDAQ: HCWB) CEO Hing C Wong acquired a total of 18500 shares at an average